Drug Trial Radar · NCT06046443
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity
Last checked: Nov 19, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
28
Actual
Start
Jul 11, 2024
Primary completion
Feb 9, 2026
Study completion Feb 9, 2026
Sponsor
- Lead sponsor
- Rhythm Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 21, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this study was to determine how well LB54640 (also known as bivamelagon) worked and how safe it was in participants with Hypothalamic Obesity (HO). The study evaluated the effect of bivamelagon on safety, weight reduction, hunger, and quality of life in participants 12 years of age and older with HO. Participants took an oral daily dose of either bivamelagon (low, middle, or high dose) or placebo through Week 14. Eligible participants who consented to continue in the study after Week 14 took an oral daily dose of bivamelagon through Week 52.
Conditions
- Hypothalamic Obesity
Interventions
BivamelagonDrug
Oral daily administration
PlaceboDrug
Placebo matched to LB54640
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment Phase: Mean Percentage Change From Baseline to Week 14 in Body Mass Index (BMI)Time frame: Baseline, Week 14
Locations
10 sites in 2 countries. Site status is shown where the registry gives one.
Children's Hospital Colorado
Aurora, Colorado
University of Iowa Children's Hospital
Iowa City, Iowa
Tufts Medical Center
Boston, Massachusetts
Columbia University
New York, New York
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Lynn Health Science Institute
Oklahoma City, Oklahoma
St. Jude Children's Research Hospital
Memphis, Tennessee
Birmingham Women's and Children's NHS Foundation Trust
Birmingham, United Kingdom
University of Cambridge
Cambridge, United Kingdom
Great Ormond Street Hospital for Children
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.